STUDY ON PERCEPTION OF PHYSICIANS TOWARDS ADVERSE DRUG REACTION REPORTING

A SURVEY IN INDIA

Abstract

Ongoing assessment for a positive risk–benefit profile of any medicinal product is an important aspect of lifecycle management; it is also a regulatory requirement. Important stakeholders in this process of pharmacovigilance (PV) are the patients, healthcare practitioners, pharmaceutical companies and regulatory agencies. Despite the regulations for post-marketing drug safety monitoring being well-defined, the rate of reporting of adverse drug reaction (ADR) by the healthcare community continues to be inordinately low.